The global epidemiological situation of schistosomiasis and new approaches to control and research
- PMID: 12020886
- PMCID: PMC5633073
- DOI: 10.1016/s0001-706x(02)00045-1
The global epidemiological situation of schistosomiasis and new approaches to control and research
Abstract
While the distribution of schistosomiasis has changed over the last 50 years and there have been successful control programmes, the number of people estimated to be infected or at risk of infection has not been reduced. Today, 85% of the number of infected people are estimated to be on the African continent where few control efforts are made. In terms of disease burden, there is therefore a growing discrepancy between sub-Saharan Africa and the rest of the world. WHO has now developed a dual strategy for the control of schistosomiasis: a strategy for morbidity control adapted to the public health context in high burden areas, and a strategy to consolidate control in areas where a low endemic level has been reached and elimination may be feasible. Related to this new vision, some research needs are pointed out.
Figures
References
-
- Appleton C, Mbaye A. Praziquantel - quality, dosages and markers of resistance. Trends in Parasitol. 2001;17:356–357. - PubMed
-
- Carabin H, Guyatt H, Engels D. A comparative analysis of the cost-effectiveness of treatment based on parasitological and symptomatic screening for Schistosoma mansoni in Burundi. Trop Med Parasitol. 2000;5:192–202. - PubMed
-
- Chen MG, Zheng F. Schistosomiasis control in China. Parasitol Int. 1999;48:11–19. - PubMed
-
- Doenhoff M, Kimani G, Cioli D. Praziquantel and the control of schistosomiasis. Parasitol Today. 2000;16:364–366. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
